Skip to main content
Simcere Pharmaceutical Group Limited logo

Simcere Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · S2P ISIN · HK0000658531 HKEX Manufacturing
Open in API
Filings indexed 577 across all filing types
Latest filing 2024-05-08 Transaction in Own Shar…
Country CN China
Listing HKEX S2P

About Simcere Pharmaceutical Group Limited

https://www.simcere.com/en/

Simcere Pharmaceutical Group Limited is an R&D-driven pharmaceutical company specializing in the discovery, development, and commercialization of innovative and branded generic prescription drugs. The company strategically focuses on core therapeutic areas, including neuroscience, anti-oncology, and inflammatory diseases. Simcere emphasizes synergistic innovation, evidenced by its development and launch of multiple Category I innovative pharmaceuticals and its strategic collaborations with global partners to advance novel treatments. These partnerships aim to address significant unmet medical needs and expand the company's portfolio across specialized disease areas.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Simcere Pharmaceutical Group Limited. It details multiple repurchases of shares with dates, quantities, and prices, confirming compliance with listing rules. The content focuses on share repurchase activities and changes in issued shares, consistent with disclosures required for transactions in own shares. There is no indication of financial statements, earnings data, or management commentary. The document is not an announcement of a report but a detailed disclosure of share repurchase transactions. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS).
2024-05-08 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Simcere Pharmaceutical Group Limited. It details multiple repurchases of shares with dates, quantities, and prices, confirming compliance with listing rules. The content is regulatory in nature, reporting share repurchase transactions and capital changes, not a financial report or earnings release. It is a formal disclosure of share repurchase activity, fitting the category of 'Transaction in Own Shares' (POS). The document length and detail confirm it is the report itself, not just an announcement or certification.
2024-05-07 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Simcere Pharmaceutical Group Limited. It details multiple repurchases of shares with dates, quantities, and prices, confirming compliance with listing rules. The content focuses on share repurchase activities and disclosures required by the Stock Exchange of Hong Kong. There is no indication of a full financial report, earnings release, or management discussion. The document is a regulatory disclosure about share repurchases, fitting the category of a report on transactions in own shares (share buybacks). Therefore, the appropriate classification is 'Transaction in Own Shares' (POS). The document length and detail support a high confidence score.
2024-05-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return on movements in securities for Simcere Pharmaceutical Group Limited, specifically focusing on issued shares, share options, warrants, convertibles, and other share-related movements for the month ended 30 April 2024. It is submitted to the Hong Kong Exchanges and Clearing Limited and includes data on share repurchases and confirmations related to share capital. The document is regulatory in nature, reporting share capital changes and movements but does not contain financial statements, earnings data, or management discussion. It is not an announcement of a report but a regulatory filing itself. The content fits the category of Regulatory Filings (RNS) as it is a compliance document reporting share capital movements under exchange rules, not a financial report or announcement of voting results or capital changes per se.
2024-05-06 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Simcere Pharmaceutical Group Limited. It details repurchases of shares on various dates, including quantities and prices, and confirms compliance with listing rules. The document is a regulatory disclosure about share repurchases and changes in issued shares, not a financial report or earnings release. It fits the description of a 'Transaction in Own Shares' filing, which reports the company's buyback activities. The document length is over 12,000 characters and contains detailed transactional data, confirming it is the report itself, not just an announcement. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2024-05-03 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Simcere Pharmaceutical Group Limited. It details multiple repurchases of shares with dates, quantities, and prices, confirming compliance with listing rules. The content is a regulatory disclosure about share repurchases, not a full financial report or earnings release. It is a formal notification of transactions in the company's own shares. Therefore, it fits the category of 'Transaction in Own Shares' (POS). The document length and detail support this classification with high confidence.
2024-04-30 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.